ストックスクリーナーアプリを入手
6.19
1.12%
-0.07
プレマーケット:
5.80
-0.39
-6.30%
前日終値:
$6.26
開ける：
$6.3
24時間の取引高:
99,104
Relative Volume:
0.45
時価総額：
$244.43M
収益：
$68.68M
当期純損益:
$-60.84M
株価収益率:
-3.8688
EPS:
-1.6
ネットキャッシュフロー:
$-38.42M
1週間 パフォーマンス:
-9.50%
1か月 パフォーマンス:
+0.65%
6か月 パフォーマンス:
-21.84%
1年 パフォーマンス:
-52.42%
1日の値動き範囲:
$6.12
$6.50
1週間の範囲:
$6.12
$7.008
52週間の値動き範囲:
$5.46
$14.84
Pulmonx Corp Stock (LUNG) Company Profile
LUNG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
6.19 | 244.43M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-06-04 | 開始されました | Lake Street | Buy |
| 2024-02-23 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 開始されました | Craig Hallum | Buy |
| 2023-02-27 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-12-12 | アップグレード | Citigroup | Neutral → Buy |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 開始されました | Citigroup | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Neutral |
| 2021-03-10 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-01-04 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-10-26 | 開始されました | BofA Securities | Buy |
| 2020-10-26 | 開始されました | Canaccord Genuity | Buy |
| 2020-10-26 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 開始されました | Stifel | Buy |
| 2020-10-26 | 開始されました | Wells Fargo | Equal Weight |
すべてを表示
Pulmonx Corp (LUNG) 最新ニュース
Pulmonx director French Glendon E. III sells shares worth $29,625 - MSN
Pulmonx director French Glendon E. III sells shares worth $29,625 By Investing.com - Investing.com Canada
Pulmonx Co. (NASDAQ:LUNG) Shares Bought by Barclays PLC - Defense World
JPMorgan Chase & Co. Buys 25,002 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Brokerages Set Pulmonx Co. (NASDAQ:LUNG) Price Target at $12.75 - MarketBeat
Geode Capital Management LLC Increases Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Barclays PLC Boosts Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World
State Street Corp Buys 18,592 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives $12.75 Average Price Target from Analysts - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Citi downgrades Pulmonx stock to Neutral stock, citing lack of clear catalysts for growth - Investing.com
Pulmonx's (LUNG) "Neutral" Rating Reaffirmed at Citigroup - MarketBeat
Jacobs Levy Equity Management Inc. Sells 188,926 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Shares Purchased by Fmr LLC - Defense World
Fmr LLC Increases Holdings in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Polar Asset Management Partners Inc. Takes Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Atom Investors LP Trims Stock Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx corp general counsel sells shares worth $34,004 By Investing.com - Investing.com Nigeria
Pulmonx chief commercial officer sells shares worth $27,063 By Investing.com - Investing.com Canada
Pulmonx corp general counsel sells shares worth $34,004 - Investing.com
Pulmonx chief commercial officer sells shares worth $27,063 - Investing.com
Parkman Healthcare Partners LLC Acquires Shares of 206,444 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx director French sells $132,600 in stock By Investing.com - Investing.com Nigeria
Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World
Pulmonx director French sells $132,600 in stock - Investing.com
Millrace Asset Group Inc. Purchases Shares of 167,725 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? - Yahoo Finance
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Yahoo Finance
Endobronchial Valve System Market Explosive Growth - openPR
FMR LLC Bolsters Stake in Pulmonx Corp - GuruFocus.com
Morgan Stanley's Strategic Reduction in Pulmonx Corp Holdings - GuruFocus.com
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Yahoo Finance
Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know - Yahoo Finance
Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results - Yahoo Finance UK
Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Pulmonx Corporation (NASDAQ:LUNG) Q3 2024 Earnings Call Transcript - Insider Monkey
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Earnings call: Pulmonx reports solid growth and strategic advances in Q3 - Investing.com UK
Pulmonx Corp (LUNG) Q3 2024 Earnings: Revenue Hits $20.4M, EPS a - GuruFocus.com
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... - Yahoo Finance UK
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... By GuruFocus - Investing.com Canada
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates - MSN
Pulmonx earnings beat by $0.81, revenue topped estimates - Investing.com
Pulmonx Reports Third Quarter 2024 Financial Results - Yahoo Finance
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
nVerses Capital LLC Buys Shares of 3,100 Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx (LUNG) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Pulmonx director sells $130,399 in common stock By Investing.com - Investing.com South Africa
Pulmonx director sells $130,399 in common stock - Investing.com India
Pulmonx Corp (LUNG) 財務データ
収益
当期純利益
現金流量
EPS
3.55%
大文字化:
|
ボリューム (24 時間):